Form 4 holding
Chief Financial Officer
MoonLake Immunotherapeutics
- Security class
- Class A ordinary shares, par value $0.0001 per share
- Shares / value
- 1,115,435
- Estimated value
- $24,584,187
- Report date
- 22 Jun 2026
- Price
- $22.04
- Ownership
- Direct